PCI Biotech Holding Logo

PCI Biotech Holding

ISIN: NO0010405640 | Ticker: PCIB
Sector: Health CareSub-Industry: Biotechnology
Country: Norway

About PCI Biotech Holding

Company Description

PCI Biotech (OSE:PCIB) is a biopharmaceutical company focusing on development and commercialisation of novel therapeutic solutions for improved treatment of cancer patients through its innovative photochemical internalisation (PCI) technology platform. PCI induces triggered endosomal release that can be used to unlock the true potential of a wide array of therapeutic modalities.

The company is applying PCI to two distinct paradigms:

- fimaVACC - Enhanced T-cell induction for therapeutic vaccination
- fimaNAC - Nucleic acid therapeutics delivery

Clinical proof-of-concept has been achieved in the lead programme fimaVacc, which applies a unique mode of action to enhance the essential cytotoxic effect of therapeutic cancer vaccines. The fimaNAc programme utilises the triggered endosomal release to provide effective intracellular delivery of nucleic acids, such as mRNA and siRNA therapeutics.

Year founded


Served area



Ullernchausseen 64, 0379 Oslo – Norway

Filings & Publications

Sign up and we will give you access!

Insider Trades

Sign up and we will give you access!

Capital markets information




Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences





Listed Stock Exchange

Oslo Børs

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.